An Automated Diagnostic Tool for Predicting Anatomical Response to Radiation Therapy by Harris, Carley Elizabeth
University of Tennessee, Knoxville 
TRACE: Tennessee Research and Creative 
Exchange 
Doctoral Dissertations Graduate School 
12-2009 
An Automated Diagnostic Tool for Predicting Anatomical 
Response to Radiation Therapy 
Carley Elizabeth Harris 
University of Tennessee - Knoxville 
Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss 
 Part of the Nuclear Engineering Commons 
Recommended Citation 
Harris, Carley Elizabeth, "An Automated Diagnostic Tool for Predicting Anatomical Response to Radiation 
Therapy. " PhD diss., University of Tennessee, 2009. 
https://trace.tennessee.edu/utk_graddiss/606 
This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee 
Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized 
administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact 
trace@utk.edu. 
To the Graduate Council: 
I am submitting herewith a dissertation written by Carley Elizabeth Harris entitled "An 
Automated Diagnostic Tool for Predicting Anatomical Response to Radiation Therapy." I have 
examined the final electronic copy of this dissertation for form and content and recommend 
that it be accepted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy, with a major in Nuclear Engineering. 
J. Wesley Hines, Major Professor 
We have read this dissertation and recommend its acceptance: 
Lawrence Townsend, Chris Pionke, Chester Ramsey, Laurence F. Miller 
Accepted for the Council: 
Carolyn R. Hodges 
Vice Provost and Dean of the Graduate School 
(Original signatures are on file with official student records.) 
To the Graduate Council: 
 
 
I am submitting herewith a dissertation written by Carley Elizabeth Harris entitled “An 
Automated Diagnostic Tool for Predicting Anatomical Response to Radiation Therapy.”  I have 
examined the final electronic copy of this dissertation for form and content and recommend that 
it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, 
with a major in Nuclear Engineering. 
 
 
       J. Wesley Hines, Major Professor 
 
We have read this dissertation 












      
 
 
Laurence F. Miller 
      
Accepted for the Council: 
 
Carolyn R. Hodges 
      
Vice Provost and Dean of  
The Graduate School 
AN AUTOMATED DIAGNOSTIC TOOL FOR PREDICTING 










A Dissertation  
Presented for the  
Doctor of Philosophy 
Degree 



















I would like to acknowledge and thank those who helped me during my years of study in 
Nuclear Engineering. I would first like to thank Dr. J. Wesley Hines for serving as my major 
professor. His knowledge as a professor and guidance as a mentor have been greatly valued and I 
am honored that I had the opportunity to finish my graduate study under his supervision. I also 
would like to thank the other members of my committee, Dr. Chester Ramsey, Dr. Lawrence 
Townsend, Dr. Christopher Pionke, and Dr. Laurence F. Miller, who have all provided me with 
both personal and academic guidance through my years at the University of Tennessee, 
Knoxville. They all are excellent professors and I am appreciative of their willingness to serve on 
my committee. 
I would also like to give a special acknowledgment to Dr. Alexander Usynin, who created 
the tool that was used to collect all of my data. Also, I would like to thank him for all of the time 
that we spent discussing my project and for sharing his useful knowledge about prediction 
modeling.    
I want to thank all of the professors and staff at the University of Tennessee who 
continued to give me support through my years as a student. A special thank you goes to my 
family in Estabrook, where Janet Coward, Dr. Roger Parsons, and Dr. Christopher Pionke greatly 
contributed to both my personal and academic growth and allowed me the opportunity to teach 




I would like to thank Dr. H. Lee Dodds for helping me find my way into the Nuclear 
Engineering Department and for all of the encouraging words and guidance that I received from 
him during my graduate years.     
 Finally, I want to thank my all of my family and friends for their continued 





















A "Clinical Decision Support System" (CDSS) is a concept which has advanced rapidly 
in health care over the last few decades, and it is defined as "an interactive computer program 
that is designed to assist physicians and other health professionals with decision-making tasks." 
Radiation therapy oncologists are required to make decisions that do not involve making a 
disease diagnosis. Therefore this work focuses on developing a modified CDSS which can be 
used to aid oncology staff in identifying cancer patients who will require adaptive radiation 
therapy (ART). 
An image-guided radiation therapy (IGRT) tool was developed that consists of both 
diagnostic and prognostic processes. Patients who will require ART are those whose cross-
sectional neck measurements change by more than half of a centimeter over the entire course of 
treatment. First, the tool allows one to “diagnose” or identify which patients would benefit from 
adaptive therapy and then make a “prognosis,” or identify when ART is required.  
Thirty head and neck (H&N) patients were used in this study, and 15 required ART.  
Each diagnosis was made by predicting if the threshold of 0.5 cm would be crossed for each of 
the four cross-sectional measurements, and each prediction was made by determining when the 
threshold would cross. The diagnosis results show that half (61/120) of the measurements 
predicted that patients would need ART given the first 15 observations and 28 of 120 predicted 
needing ART within 20 observations. Therefore, 74% of patients' measurements accurately 
diagnosed that ART would be required given just the first 20 observations. The prediction results 




reliability of at least 0.5. However, more accurate time predictions with higher reliability values 
(0.6 and 0.7) could be made given an average of 16 and 18 observations, respectively. These 
predictions, while requiring more observations, provided additional lead time in knowing when 
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 The primary goal of radiotherapy is to destroy tumor cells contained in a volume. This 
volume is physician-defined and is often times located nearby or in normal, healthy tissue in the 
body. There becomes a certain compromise or conflicting goal when treating with radiotherapy, 
because it is desired to use enough radiation to treat the pre-defined target volume while still 
sparing the function of surrounding normal tissues and structures. In order to find the best 
compromise and have a successful outcome of the primary goal, both accurate and reproducible 
radiation treatments must be delivered over the entire course of therapy.    
External-beam radiation therapy (EBRT) involves treating cancer patients with radiation 
which leaves the source (linear accelerator) and enters through the skin. It has been in use for the 
last 100 years and in the last eight decades it has proven to be an effective therapeutic means for 
controlling and even curing cancer. In the last fifty years, rapid technological advances have 
allowed for the progression of exceptional radiation therapy treatment for all types of cancer 
patients.  
  
1.1 BACKGROUND AND RESEARCH NEED 
Head and neck (H&N) cancer is one type of cancer that can be a challenge to treat. There 
are a few options for treatment, including radiation therapy, chemotherapy, surgery, or a 
combination of these. When using radiation therapy, H&N cancer can be difficult to treat in 
terms of covering the tumor adequately, avoiding normal tissues, and delivering the radiation to a 




is to deliver an accurate and reproducible treatment. To be accurate, normal structures, such as 
saliva-producing parotid glands, spinal cord, and optic nerves, must be avoided, and 
reproducibility is achieved with the use of immobilization devices. 
H&N patients are of particular interest in radiation therapy because they are known to 
incur large anatomical changes (weight loss, tumor shrinkage) over the course of treatment. If 
large enough changes occur, the immobilization device, or facemask, can become ineffective in 
holding a patient stationary and treatment plans can become invalid due to the delivery of 
inaccurate doses. Once the accuracy and reproducibility of a plan is compromised, there is need 
for an adjustment before the completion of a patient’s treatment. Therefore, the two main 
concerns for head and neck patients are that the facemask is correctly immobilizing the patient's 
head during treatment and that the correct radiation dose is being delivered. If either one of these 
is compromised, then there becomes a need for adaptive therapy. One might ask, "How do we 
know which patients are incurring large anatomical changes?" or "At what point during the 
course of treatment should we be concerned about delivering an incorrect radiation dose due to 
an ineffective facemask?" Answering these questions ultimately identifies those head and neck 
patients who would "benefit from adaptive radiation therapy," and finding the answers is the 
main focus of this dissertation. 
The main problem is quantifying “significant anatomical change” and determining which 
patients have undergone enough change to require a new facemask and/or a new treatment plan. 
While the main focus of this dissertation is to identify those patients who will need a new 
facemask, it is still important to note the consequences of not having a new mask, meaning the 




it is possible for a patient to experience increased doses to normal tissue while under-dosing the 
tumor volume. This is extremely undesirable due to a chance of tumor recurrence or toxicity to 
the patient.  
Figures 1 and 2 illustrate exactly why there is a need for adaptive radiation therapy. The 
first patient experienced such significant tumor response to treatment that the mask no longer 
touched the sides of the face, which should have required a new mask to be made. However, no 
new mask was made and the reason for this is unknown. The second patient experienced changes 
that caused the doses to shift, risking over-irradiating the spinal cord, and the middle image 
shows what would have been delivered if no adaptive therapy had taken place. However, a new 
treatment plan was developed and the last image shows the corrected plan which is no longer 
directly delivering dose to the patient's spinal cord.     
Many times in a real clinic setting, the oncologist is unaware of significant changes such 
as those shown for these patients. Therefore a method should be available for when to implement 
adaptive therapy, where patients requiring additional attention could be identified and the 
physician could proceed with the appropriate line of action. Methods are currently available for 
making decisions regarding a diagnosis, but cancer patients have already been diagnosed and 
















A "Clinical Decision Support System" (CDSS) is a concept which has advanced rapidly 
in health care over the last few decades. The idea of having computer-aided diagnostic tools 
began back in the 1970's [de Dombal et al. 1972], and a CDSS is defined as "an interactive 
computer program that is designed to assist physicians and other health professionals with 
decision-making tasks." More recently, a CDSS could be knowledge-based or non-knowledge-
based, and the methodologies used by the systems are already well-known for their problem-
solving abilities. Examples of these methods include Bayesian Networks, Neural Networks, 
Genetic Algorithms, Rule-Based Systems, Logical Condition, and Causal Probabilistic 
Networks. All methods are useful in the development of a CDSS, and much research has been 
done on the feasibility and effectiveness of using the system to make a decision or diagnosis 
[Johnston et al. 1994]. While the popularity of these systems is growing for many general 
practicing physicians, radiation oncologists are required to make slightly different types of 
decisions which do not involve making a disease diagnosis. Therefore, a modified CDSS, such as 
the IGRT tool presented in this work, can be used to aid oncology staff in decision-making 
processes.            
The idea of compensating for changes and customizing treatment plans to individual 
cancer patients was first introduced by members of the Department of Radiation Oncology at the 
William Beaumont Hospital [Yan et al. 1997a]. Termed adaptive radiation therapy, the idea was 
proposed as a closed-loop radiation treatment process where treatment plans could be modified 
by using a systematic feedback of measurements. The first use of this process was measuring and 
correcting for treatment position variation, with mention of eventually extending it to the 




Many aspects of radiation therapy have to be monitored and checked during the course of 
treatment, including patient positioning, doses delivered to the tumor and surrounding tissue, and 
normal/tumor tissue response to radiation. After the concept of ART was introduced, many 
studies involving imaging and adaptive therapy followed, attempting to address all of these 
aspects. For example, Yan et al. [1998] conducted an ART feasibility study using portal imaging 
to evaluate patients for setup error due to incorrect patient positioning, finding that ART was 
extremely valuable in routine clinical practice for reducing systematic errors. Hansen et al. 
[2006] evaluated the dosimetric effects on target volumes and normal tissues by repeating and 
evaluating daily CT scans. Work done by Barker et al. [2004] involved quantifying volumetric 
and geometric tumor changes that occurred for H&N patients during courses of radiotherapy. 
These three studies have been extensively referenced in other publications whenever adaptive 
therapy is mentioned. They all conclude that using available imaging technology along with 
ART is extremely valuable and that systematic measurements and data can be useful in the 
development of an ART scheme.  
True implementation of an ART process will require a new infrastructure where the 
clinical procedures such as treatment planning, treatment verification, treatment evaluation, and 
treatment adjustment are not performed as independent tasks. This dissertation will concentrate 
on the treatment evaluation and adjustment parts of an ART process by developing an off-line 
image-guided radiation therapy tool. This tool will allow for H&N patient measurement data to 
be evaluated and provide feedback to the radiation oncologists so that any necessary adjustments 
can be made. In addition to describing the model used to build the tool, this dissertation will 




measurements can be automatically made and analyzed while the patient is undergoing 
treatment.  
Table 1 shows a description of the 30 patients used to develop the IGRT tool. The 
demographic information is shown to point out that several types of diseases and staging were 
used for the study, and that an effective ART method should accommodate any type of H&N 
patient. Other demographic information, such as whether or not a patient was receiving 
chemotherapy during radiation, surgery status, as well as total prescribed dose were also 




Table 1: Patient demographic information 
Patient 
Number 
Primary Site Stage Pathology 
Chemo-
therapy 
Surgery Dose (Gy) 
1 Unknown TXN2M0 Squamous Concurrent Post-Op 66.0 
2 Unknown TXN1M0 Squamous Concurrent None 70.2 
3 Tonsil T2N1M0 Squamous Concurrent None 61.2 
4 BOT* rTXNXM0 Squamous Concurrent None 68.0 
5 Larynx T3N0M0 Squamous Concurrent None 66.4 
6 Epiglottis T2N0M0 Squamous Concurrent None 66.0 
7 BOT T1N1M0 Squamous Concurrent Post-Op 66.0 
8 BOT T1N1M0 Squamous None Post-Op 60.0 
9 Tongue T2N1M1 Squamous Concurrent None 68.4 
10 Pharynx T2N1M0 Squamous Concurrent None 62.1 
11 Supraglottic Larynx T2N2bM0 Squamous Concurrent None 64.0 
12 BOT rT3N3M0 Squamous Concurrent None 68.5 
13 Pyriform Sinus T4N1M0 Squamous Concurrent None 70.2 
14 Epiglottis TXN2bM0 Squamous Concurrent None 50.0 
15 Tonsil T2N2M0 Squamous None Post-Op 61.2 
16 Unknown TXN1M0 Squamous Concurrent Post-Op 64.8 
17 Nasopharynx T3N0M0 Squamous Concurrent None 70.2 
18 Larynx rTXN2M0 Squamous Concurrent None 50.0 
19 BOT T4N2M0 Squamous Concurrent None 67.6 
20 Retromolar Trigone T2N1M0 Squamous Concurrent Post-Op 52.2 
21 Oral Tongue T2N0M0 Squamous None Post-Op 63.0 
22 Supraglottic Larynx T2N0M0 Squamous None None 70.0 
23 BOT T1N2aM0 Squamous Concurrent None 52.0 
24 Unknown TXN1M0 Squamous Concurrent None 63.0 
25 Nasopharynx TXN0M0 Adenoid Systic None Post-Op 61.2 
26 Retromolar Trigone T2N0M0 Squamous None None 70.0 
27 BOT T1N2aM0 Squamous Concurrent None 70.4 
28 Tonsil T2N1M0 Squamous Concurrent Post-Op 63.0 
29 Nasopharynx T2N1M0 Squamous Concurrent Post-Op 70.4 
30 Pharynx T2N0M0 Squamous Concurrent None 59.4 






1.2 ORIGINAL CONTRIBUTIONS 
Many studies published in the literature in the last ten years have identified the problems 
associated with anatomical changes in H&N patients by analyzing tumor volume regression, 
parotid shift data, parotid volume loss, and dose reconstruction data; but none have determined 
which specific patients should (and when) have their plans adapted. In this study, a new type of 
data will be analyzed with an approach that has never been used before in order to determine 
which patients would "benefit from ART." An outline of the original contributions of this 
dissertation is presented below.  
 
1. Development of a method for identifying which head & neck patients would most 
benefit from adaptive radiation therapy, with a focus on those patients who will 
require a new facemask. The method employs 4 different cross-sectional 
measurements, taken from the neck region, and evaluates the change in measurement 
for each.  
2. Development of a reliability metric for the H&N patients identified as needing 
adaptive radiation therapy. 
3. Development of a method for predicting when H&N patients will need ART. 
4. A metric for reporting reliability when making a prediction, which will aid the 
oncologist in making a decision. The reliability metric takes into account how well 
measurements are correlated along with a “closeness to crossover” parameter, which 
is a measure of how close (in time), a patient’s measurements are to crossing a 




5. An original automated Image-Guided Radiation Therapy tool to analyze the collected 
head & neck measurement data. The two-part IGRT tool will aid oncologists and 
physicists in the clinical setting by alerting them if and when patients will require 
adaptive radiation therapy during the course of their treatment. With the ability to 
make an accurate prediction, time and resources can be pre-allocated to take into 
account the extra work load from having to create new treatment plans and/or a new 
facemask.  
 
1.3 DOCUMENT ORGANIZATION 
 A detailed literature survey of current radiotherapy practices, the advent of image-guided 
radiation therapy, and the use of new treatment techniques to implement adaptive radiation 
therapy is presented in section 2. Next, the methodology for developing the IGRT tool will be 
discussed in section 3. Then in section 4, the results of using this tool as an integrated decision 
making process are presented. Finally, section 5 concludes the dissertation and provides 




2 LITERATURE SURVEY 
 This section provides a literature survey of the need and benefits for treating head and 
neck cancer patients with adaptive radiation therapy. The survey will give an overview of current 
radiation therapy practice, the recent advances in the field of radiation oncology, methods used 
for managing uncertainty associated with treating head and neck patients with radiation therapy, 




 The current clinical process for developing a radiation treatment “plan” involves first 
acquiring an image set of the patient. The majority of patients simply undergo a pre-planning 
computerized tomography (CT) scan, while some patients require additional diagnostic scans, 
such as a PET scan or an MRI series to better identify the tumor site. The images acquired are 
crucial in determining where radiation is to be delivered.  
Once diagnostic and planning images are obtained, a computerized treatment planning 
system (TPS) is utilized for contouring and calculating doses for any given volume within the 
patient. The International Commission of Radiological Units (ICRU) defines the gross tumor 
volume (GTV) as “gross palpable or visible/demonstrable extent and location of malignant 
growth.” The clinical target volume (CTV) includes gross tumor volume “and/or sub-clinical 
microscopic malignant disease which have to be eliminated.” It is the CTV that we hope to 




Another important volume used in radiation therapy, also introduced by the ICRU in 
1978, is the primary target volume (PTV), and it is typically the clinical treatment site or target 
for which a prescription of radiation dose is to be delivered. It is comprised of the CTV plus an 
appropriate margin, the extent of which is determined by the physician. The PTV was defined 
due to the recognition that there are treatment uncertainties, such as organ motion and/or patient 
positioning errors. At the end of the planning process, the product is a treatment plan with 
specifications for total radiation dose, daily treatment doses (called “fractions”), field sizes, and 
field shapes. Figure 3 illustrates how the target volumes are defined by the ICRU.    
 
 




2.2 ADVANCES IN RADIATION THERAPY 
 
 Oncologists and physicists have always been concerned with delivering the best radiation 
treatment possible to cancer patients without damaging normal, healthy tissue. An article by 
Herring and Compton [1970] explains the importance of disease control and normal tissue 
complication rates with respect to dose. Based on their evaluation, they recommend that the dose 
delivered over the course of treatment should be within ±5% in order to control local disease and 
spare normal tissue function. In order to stay within the 5%, accuracy and precision would be 
required at each step of the treatment process, and therefore some kind of system would need to 
be implemented. This system would take into consideration both dosimetric and geometric 
factors, which can adversely affect the quality and accuracy of radiation therapy treatments. 
According to Jaffray, Yan, and Wong [1999], the required geometric precision of radiotherapy 
treatments must be selected based on treatment site and cost. They explain that on-line 
techniques (where the patient is on the treatment table during measurement) are best suited for 
identifying intra-fraction setup errors and organ motion during treatment, while off-line 
strategies (done outside of patient treatments) best identify inter-fraction (daily) errors.     
 The ICRU began providing reports for recommendations and standards of radiation in the 
1950’s, and the information in ICRU report #50 [1978] has set a standard for the practices in 
radiation oncology. As mentioned before, the report defines such things as the CTV: the region 
which contains the gross tumor volume (GTV) and then a margin around for microscopic 
disease. The planning target volume (PTV) includes the CTV as well as margins to account for 




With a set of suggested limits and standards in place, oncologists and physicists 
continued to use the available tools for creating and delivering acceptable treatment plans. The 
next sections will describe the advancement of those tools, specifically the use of imaging for 
treatment verification, and how they have allowed for the advancement of adaptive therapy.        
 
2.2.1 Portal Imaging 
Early studies regarding geometric uncertainty in EBRT used portal films to evaluate 
setup errors during treatments. A study done by Marks et al. [1974] evaluated 99 lymphoma 
patients and detected 330 localization errors (out of 902 films) by using treatment verification 
films, or portal films. Their study concluded that “treatment verification films are invaluable in 
the detection of localization errors in the treatment of lymphoma, and that they can lead to a 
reduction in localization errors if they are used regularly.” Similar studies were done during the 
70’s and, due to the realization that verification films were very useful in detecting errors, the 
development of electronic portal imaging devices, or EPIDs, began. A pilot study done by Boyer 
et al. [1992] looked at the limitations of imaging with high-energy radiation beams as well as the 
different techniques used to produce EPIDs. An extensive review of optical systems using direct 
x-ray-induced fluorescence was done, and they concluded that EPIDs provided images 
comparable to radiographic film (which was the standard until the early 90’s) and were 
convenient due to the ability to store and transfer them electronically.  
Because the goal of radiotherapy is to treat cancerous tumor cells within the CTV while 
sparing normal surrounding tissues, it is necessary that patient setup errors be quantified and 




Work done by Erridge et al. [2003] examined patient set-up, tumor movement, and tumor 
shrinkage for lung cancer patients. They produced results which validated the use of EPIDs to 
reduce set-up error and to localize the tumor more accurately than with radiographic film alone. 
Hurkmans et al. [2001] reviewed clinical practices performed at The Netherlands Cancer 
Institute and developed a set of recommended allowable set-up deviations for different cancer 
sites, including H&N, prostate, pelvis, lung, and breast. These recommendations were a result of 
using EPID images to come up with criteria for “good clinical practice” in patient positioning.            
 
2.2.2 Image-Guided Radiation Therapy  
 The use of 3D imaging in radiation oncology has become routine in clinical practice. In 
the treatment planning process, images of the patient are used by the oncologists to identify the 
tumor location as well as where the relative normal tissues are located. The frequent use of 
imaging in the treatment room during a course of radiation therapy, where decisions are made 
based on these images, is called image-guided radiation therapy, or IGRT. Jaffray explains that 
this type of volumetric imaging permits “unprecedented characterization of the diseased and 
normal structures with precise and accurate determination of geometric location” [2005].  
Dawson and Sharpe [2006] reviewed IGRT in terms rationale, benefits, and limitations. 
They determined that the rationale for IGRT was to verify and guide treatments, which is 
important for identifying setup errors and daily tumor changes. The benefits of IGRT are the 
ability to measure tumor changes and reduce setup error after identification of the error. And, the 
major benefit is the ability to verify increased doses to tumors. Without the prior ability to verify 




with the advent of IGRT, higher, monitored doses can be delivered to the patient and local 
disease control and survival rates have increased. The only evident limitation is that no one 
technology or strategy exists that is appropriate for all clinical situations. But, IGRT does 
provide the opportunity to adapt radiotherapy to anatomical changes that could not be done 
previously.  
Sorcini and Tilikidis [2006] reported on the clinical application of IGRT using a Varian 
linear accelerator with an on-board imager (OBI). Their study, conducted in Stockholm, Sweden, 
evaluated using the OBI for on-line set-up correction of prostate patients using internal gold 
markers. They measured the displacements of the markers and were able to accurately track the 
position of patients’ internal anatomy.  
The usefulness of IGRT has been extensively researched and is present in most clinical 
treatment facilities in the world. IGRT allows for daily identification of the size, shape, and 
location of the tumor so that positional adjustments can be made if needed. This advantage 
permits better tumor control and reduces the risk of toxicity after radiotherapy is complete.  
 
Computed Tomography (CT) 
Originally, a single set of CT scans was acquired prior to the start of a patient’s treatment 
and used as a basis for radiotherapy planning. Soon after it was realized that the position of the 
tumor could change from fraction to fraction, routine CT-imaging prior to each daily treatment 
was adopted. The study done by Barker et al. [2004] evaluated the use of a CT/linear accelerator 




from 14 H&N patients showed that significant volumetric and positional changes occurred for 
the gross disease. By acquiring daily pre-treatment CT scans, it is possible to monitor tumor 
position and help reduce uncertainty in the treatment.  
Newer types of CT scans are currently available, such as megavoltage CT (MVCT) and 
megavoltage cone beam CT (MVCBCT) which allow for better contrast in the images. And, the 
use of integrated CT/linear accelerators is becoming more widely accepted. Helical 
TomoTherapy machines include an on-board MVCT scanner to acquire images just prior to 
treatment. Elekta’s Synergy is available with an on-board MVCBCT scanner. Megavoltage cone-
beam CT is a technique used to acquire images by using a cone shaped x-ray beam rather than a 
conventional linear fan beam, projecting it through the patient, and using a detector on the other 
side to record the attenuation of the x-rays through the patient. In contrast, MVCT images, such 
as those acquired on a TomoTherapy machine, are made by detecting a fan beam of x-rays 
projected through the patient.   
Pouliot et al. [2005] conducted a feasibility study of MVCBCT with respect to 
acquisition time and quality of images. Because of the newness of the technology, both frozen 
sheep and pig heads were scanned and images were reconstructed to evaluate the quality of bony 
anatomy identification. It was concluded that MVCBCT produced excellent images; however 
surface dose to the skin (2 cGy/film) could prevent acquiring the images every day. Oldham et 
al. [2005] evaluated an on-line application for MVCBCT and found that the images produced by 
this technique provide for excellent delineation between soft tissue and bone, allowing for 




Dawson and Jaffray recently conducted a review of the advances in IGRT and how it can 
be extended even further beyond its current uses. With the realization of the clinical benefit that 
IGRT has for verifying correct patient positioning and monitoring day-to-day anatomical 
changes, studies are now moving forward to not just identify problems, but correct them as well. 
Looking on to future applications of IGRT, “Adaptive radiation therapy can now be exploited, 
and the impact on replanning or changing the treatment course on the basis of information 
obtained during treatment can be investigated” [2007]. 
 
2.3 ADAPTIVE RADIATION THERAPY  
 
As mentioned previously, members of the William Beaumont Hospital introduced the 
term adaptive radiation therapy as “a radiation treatment process where the treatment plan can be 
modified using a systematic feedback of measurements” [1997]. The idea is simply aimed at 
improving radiation treatments by monitoring daily changes and integrating the information into 
a new, re-optimized plan, which is customized for each patient.  
The first studies done using ART involved taking portal films and making set-up 
adjustments at that time [Bel et al. 1995; Michalski et al. 1996]. This approach is termed on-line 
ART because the adaptation is done while the patient is lying on the table and used to make 
decisions regarding shifting a patient’s position on the treatment table. A newer approach, off-
line ART, is becoming more popular and it is believed to be better in terms of correcting for 
systematic and random errors [Hong et al. 2005]. Off-line adaptive therapy involves using data 




Currently, there is sufficient literature to support the idea of adapting plans during the 
course of treatment for cancer patients. Brabbins et al. [2005] conducted a dose-escalation trial 
on prostate patients and determined that using adaptive therapy to locate the internal location of 
the tumor, along with radiotherapy, allowed for reduced toxicities after the completion of 
treatment. Yan et al. [1997b] used adaptive modification of treatment planning to minimize the 
effects of set-up error, and work done by Sharpe et al. showed that adaptive planning and 
delivery is extremely effective in accounting for anatomical changes induced by radiation 
therapy [2005]. One specific new application involves tracking lung motion and lung tumors 
within the lungs. Using adaptive therapy along with image-guided TomoTherapy treatments has 
been studied for the last few years [Ramsey et al. 2004, 2006], and new techniques have been 
developed which have lead to the better treatment of lung cancer patients.  
   Only a few recent studies have addressed the issue of ART for those patients 
specifically with H&N cancer. There have been studies which identify the dosimetric effects due 
to not replanning. For example, Jenkins et al. used daily MVCT imaging to determine dose 
variations for H&N patients. They found that it is necessary to perform daily imaging so as to not 
incorrectly treat patients [2005]. Doemer et al. came to a similar conclusion after analyzing 15 
H&N patients and determining that adapting patient plans was frequently necessary due to 
increasing doses to the spinal cord [2008]. Other studies, such as the one done by Wu et al. 
[2007] looked at adaptive replanning strategies accounting for tumor and normal tissue shrinkage 
for patients undergoing treatment. These studies emphasize how essential it is to evaluate both 




In the literature, there have been no new approaches for identifying which patients would 
benefit from ART and then when exactly those plans should be adapted during the course of 
radiotherapy treatment. The first step in ART is identifying the places for possible uncertainty 
and error in a patient’s radiotherapy treatment.  
 
2.3.1 Identifying Uncertainty and Error 
A review was conducted of the advances in identifying uncertainty [Jaffray et al. 1999]. 
From this reviewing of the current literature, it was found that uncertainty typically is 
characterized as either setup errors or organ motion. Setup errors are a result of variations in the 
positioning of the patient’s bony anatomy, while organ motion is variation in the target (tumor) 
within the patient. It was concluded that the magnitude of organ motion errors were significantly 
less than setup errors and accommodations in planning procedures should be made.     
As mentioned before, the study done by Hurkmans et al. [2001] did an extensive 
evaluation of set-up verification using portal imaging in their clinic. The study separated setup 
errors into two main classes: random and systematic. Random errors are inter-fraction errors 
which are deviations between fractions, and systematic errors are deviations between the planned 
patient position and the average patient position over a course of fractionated therapy.  
Being able to identify potential errors allows for correction before a patient is treated 
incorrectly. As such, daily setup variation should be incorporated into plans in order to achieve 
the best treatment. Studies have been done on predicting systematic and random errors [Zeidan et 




while evaluating setup error is extremely important, other sources of error should not be 
overlooked when using an adaptive approach to radiation therapy.          
 
2.3.2 Anatomical Changes 
 During a radiotherapy course, many H&N patients experience substantial anatomical 
changes due tumor response, nodal mass response, edema, or overall weight loss. Wang [2007] 
looked at how body weight loss is associated with error in treating nasopharyngeal patients. 
Barker [2003] measured tumor volumes at the beginning and end of treatments, finding that the 
response to radiation can cause drastic changes in volume over the course of therapy. Meldolesi 
[2006] examined skin volume reduction and parotid size change in nine H&N patients. Lee 
[2007] measured how the parotid glands physically moved with respect to the tumor. All four 
studies measured and identified particular anatomical changes that can occur over the course of 
radiotherapy treatments, which should all be taken into consideration by the radiation therapy 
staff.     
These changes in anatomy can prove to be a problem if they affect the quality of a 
patient’s radiation treatment. A few studies have identified H&N patients as potential ART 
candidates due to their response to radiation treatment [Feng & Eisbruch 2007; Meyer et al. 
2007], while several studies have evaluated tumor response by looking at images taken from 
various IGRT devices. Because immobilization devices, such as masks and bite-blocks placed in 
the mouth, are typically used to hold the patient in place during treatment, losing weight or a 
reduced tumor mass can take away from the effectiveness of the device. As such, it might be 




Tumor Response to Radiation 
Barker et al. [2004], as previously mentioned, conducted a retrospective study to 
determine the dosimetric effects on normal tissue and tumor volumes using daily CT scans and 
replanning during the course of IMRT. The study reported that the gross tumor volume 
decreased throughout the course of radiotherapy at a median rate of 1.7% - 1.8% per day, and the 
volume loss was frequently asymmetric. Figure 4 shows an example of how rapid anatomy can 
change (especially the tumor) during radiation therapy. The left panel depicts the CT image prior 
to treatment, and the right panel shows the same image after the patient had undergone 3 weeks 
of treatment. Changes such as this would most likely require the patient to have their plan 

















Figure 4: Rapid anatomy changes for one H&N patient (a) before and (b) three weeks into 








 H&N patients can also experience significant weight loss during their course of 
radiotherapy. This can be due to tumor shrinkage or overall weight loss. This effect, along with 
tumor response, could potentially result in an under-dosage of the tumor/target tissue or an over-
dosage to normal tissues. The same study done by Barker with regard to tumor response also 
involved evaluating dosimetric consequences due to weight loss. The study reported a median 
weight change from start to finish of treatment as -7.1%.  Therefore, it is evident that weight loss 
plays a significant role in determining if a patient will require ART. A review of IGRT in terms 
of its rationale, benefits, and limitations was previously mentioned [Dawson & Sharpe 2006]. 
Figure 5 shows two cone-beam CT images taken of the same patient at the beginning of 
treatment (A) and then after 3 weeks (B) of treatment, and anatomical change (weight loss) can 
clearly be seen when using this imaging modality.   
 
 





2.4 IGRT FOR ART IMPLEMENTATION 
 The use of daily imaging has been proven to aid oncologists and therapists is identifying 
when changes have occurred during the course of therapy. With these daily images, it is possible 
to conduct retrospective analysis for any given patient. At the Thompson Cancer Survival Center 
in Knoxville, TN, a Helical TomoTherapy machine is used daily to treat the majority of H&N 
patients who are undergoing external beam radiation therapy. This machine includes an on-board 
CT scanner which is used to acquire daily pre-treatment images for the purpose of verifying the 
correct set-up of the patient. When a patient is finished with their treatment, their information is 
archived in a database.  
 The most significant ART studies done using IGRT were done by Barker [2004] and 
Hansen [2006]. Both authors extensively evaluated volumetric, geometric, and dosimetric effects 
on H&N patients without replanning their treatments. In 2004 Barker used “high-definition 
imaging studies throughout the treatment course to quantify the magnitudes and rates of three-
dimensional anatomic changes occurring gradually over time.” It was concluded that GTV’s 
typically regress asymmetrically and that the results might have potential dosimetric implications 
when conformal treatments are used. In 2006, Hansen and his co-authors followed up that study 
by performing repeat CT scanning to evaluate doses to target volumes and normal tissues. They 
reported not being able to separate the effects of tumor shrinkage and weight loss due to the 
small sample size (n=5) of patients. And, that “future studies should investigate the effects of 
asymmetric location of normal structures and/or target volumes, asymmetric volume losses, and 




tissues.” The results from these two studies suggest the great need for a tool to aid clinicians in 
determining which patients should have their plans adapted.  
It is known that imaging in the treatment room has provided extensive data which 
documents movement and anatomic change of targets during and between treatment fractions. 
Many investigators demonstrated this in their studies by using 3D images to obtain tumor 
response measurement data [Kupelian et al. 2005; Sohaib et al. 2000; Siker et al. 2006]. This 
data can be incorporated with the various anatomical changes in order to manage target 
movement and setup uncertainty. For example, a few studies have reported using daily CT 
images to aid in adaptive procedures [Liang et al. 2008; Lu et al. 2006]. The only question that 
has yet to be answered is how exactly to implement the data (obtained from IGRT devices) into a 
decision making process. 
 
2.5 CLOSING REMARKS 
Most studies that have involved measuring initial tumor volume propose a “percent loss 
threshold” approach for future studies in order to make an ART decision. For example, one 
recent study suggested that if the tumor volume is reduced by 30%, then a new plan should be 
created [Woodford et al. 2007]. This is a valid approach, but patients can lose body weight 
without losing tumor volume.  
For instance, if a patient were prescribed 1.8 cGy in 35 fractions but then lost a 
significant amount of weight in the first 15 fractions, it would be of interest to the oncologist to 
as to how this would affect the outcome of the remaining 20 fractions of the radiation treatment 




weight in the first 15 fractions to cause the parotid glands to move into the PTV and the tumor 
never reached that threshold, one could potentially damage the patient’s salivary function.  
As stated before, the best way to have an overall successful outcome of treatment, both 
accuracy and reproducibility must exist in radiotherapy. When a patient loses weight or 
experiences anatomical change to radiation, these two principles can become compromised. 
Accuracy is lost if a tumor is no longer receiving the prescribed dose (thereby under-dosing) or if 
normal structures are receiving too much dose. Reproducibility is missing if the immobilization 
device is no longer effective.  
Therefore, if a patient loses weight in the neck and an immobilization device is no longer 
effective, then they should have their treatment course adapted, and more than likely will require 
construction of a new facemask. By using a percent threshold, a patient may be overlooked when 
adapting their treatment plan would be the more appropriate line of action. By using cross-
sectional measurement data to evaluate changes in daily measurements, weight loss patients and 
tumor response patients can be distinguished and a more informed decision can be made about 
which patients (and when) would "benefit from ART." More specifically, this dissertation 






 This section will describe the basic methodology for developing the IGRT tool, which is 
the major contribution of this dissertation. The main purpose of this tool is to help in answering 
two questions. The first is, “How do we know which patients will benefit from adaptive radiation 
therapy?” The second is, "If a patient will require adaptive therapy, at what point in their 
treatment should an adaptive approach be implemented?" In other words, "How do we know 
which patients are incurring large anatomical changes, be it weight loss or tumor response?" and 
"At what point during the course of treatment should we be concerned about delivering an 
incorrect radiation dose due to an ineffective facemask and/or treatment plan?" 
The solution to answering these questions presents itself twofold: solving a diagnostic 
problem in identifying “who,” and then dealing with a prognostic-type problem to predict 
“when.” Answering these questions ultimately identifies those head and neck patients who would 
benefit from adaptive radiation therapy, and finding the answers is the main focus of this 
dissertation. Once the answers are known, the ultimate result is either:   
1. The patient is not experiencing enough anatomical response to radiation treatment to 
require adaptive therapy.  
2. The patient is experiencing significant anatomical response to radiation and will 
require adaptive therapy. If so, then: 
a. The patient needs the creation of a new treatment plan but no new facemask. 





c. The patient needs both a new facemask and a new treatment plan. 
 
To help in answering these questions, cross-sectional measurement data taken from thirty 
patients’ neck regions were evaluated based on the amount of change in the first few treatment 
fractions. By identifying those patients whose measurements exhibit early "significant change," a 
decision can be made as to whether or not a new mask should be made and/or if a new treatment 
plan should be developed. If the answer to the first question is "yes", then the second question 
will be answered by predicting at what point in time adaptive therapy is required. If the answer is 
“no” then it is assumed that the patient should require no re-evaluation.  
In this dissertation “significant change," according to the physician at the institution 
where the data was collected, is a change greater than 0.5 cm in any of the four cross-sectional 
measurements. The patients who exhibit this magnitude of change would potentially require 
ART, and these are the patients who are the most important to identify and correct for at the 
appropriate time. A description of how the data was acquired and then how it was used to 
develop a diagnostic method for answering the first question will be presented, along with the 
techniques used to make a time prediction, thereby answering the second question.  
 
 
3.1 DESCRIPTION OF THE DATA 
 
It is known that human tissue responds to radiation: large tumors tend to significantly 
decrease in size over the course of treatment, and patients tend to lose weight due to side effects 




experience gradual changes in their anatomy during radiotherapy, daily CT scans are very useful 
in identifying those changes. For the TomoTherapy machine, once a patient is scanned, the 
original planning CT image is fused along with the new scan. By looking at the superimposed 
images, significant changes in anatomy can easily be identified and measured. 
 
3.1.1 Data Collection 
Figure 6 shows an example of a patient who experienced "significant" anatomical 
changes, and for this case, it was attributed to overall weight loss. The gray image is the original 
planning image, which was acquired before the patient began treatment. The blue image was 
taken in the 5th week of treatment. It is apparent that the patient had an overall reduction in the 
neck region and perhaps more on the right side near the C2-C3 level.  
Previously discussed studies have evaluated data from volumetric changes in tumors and 
normal tissues. The results from the Hansen study show that no distinction could be made 
between the significance of tumor response and weight loss. However, by taking cross-sectional 
measurements of the head and neck region and looking at the rate of change in the first few 
treatments, it appears as though this distinction could be made. For example, if measurements 
taken on the right side of the face change at a faster rate than those on the left side, then one 
could say that patient was experiencing tumor response to radiation. However, if all 
measurements around the head and neck region are changing rapidly, one might say that patient 









Data Collection Tool 
A total of 1450 MVCT images were obtained from the TomoTherapy archive database 
and evaluated for tumor response, weight loss, and anatomical changes. Cross-sectional head and 
neck data was collected for 30 H&N patients for a total of over 30,000 measurements. These 
measurements were taken using each patient’s daily pre-treatment MVCT scans and included 
anterior-posterior (AP) and lateral (LAT) measurements. The AP measurement is beneficial 
when evaluating incorrect positioning; however it was used here only for the purpose of locating 
the midpoint of the patient’s head. Therefore, two lateral measurements were taken with respect 
to the center of each vertebral body, and two other lateral measurements were taken with respect 
to the midline of the patient’s head, which totals 4 lateral measurements for each available 




the center of the vertebral bodies. Starting with the red solid line in the figure and moving 
clockwise around the head, we have measurements one through four, respectively.  
A graphical user interface (GUI) was developed by Dr. Alexander Usynin at the 
Thompson Cancer Survival Center in Knoxville, TN for the purpose of taking these cross-
sectional measurements in a consistent and efficient manner. The tool was created in MATLAB 
and was used to recall archived imaging data, (from the TomoTherapy database) which allowed 
for the collection of the cross-sectional measurement data. Figure 8 shows an example of this 
tool, and it was used to collect all data from the 30 H&N patients. Once all daily MVCT images 
are loaded, the user has the ability to scroll through the kVCT (original) scan until the desired 
slice if found. Then, the user “Accepts Slice” and the corresponding MVCT image appears in the 



























In the right panel, the blue lines indicate the location of the slices selected for that 
particular day (which are not usually chosen consistently from day to day). The green lines 
shows the corresponding slice which is seen in the left panel. In order to maintain the 
consistency of the data for each patient, the center of each cervical vertebral body was chosen as 
a bony landmark. Most of the studies done with H&N patients, especially those evaluating setup 
error and uncertainty use the cervical vertebra as landmarks, therefore this was the reasoning 
behind using them in this study. Measurements were taken at the center of each vertebral body, 
extending from C1-C5. There are 7 cervical vertebrae, however the shoulders appear around C5 
or C6 for most patients, and it was found that the information taken at that level is not very 
useful for modeling.  
Because the images were acquired at a 3-mm slice thickness, one is able to see parts of 
each vertebral body throughout the slices. However, to maintain consistency, the center of each 
vertebra was located and used as the reference point for taking a measurement. In other words, 
measurements were taken where each vertebra appeared intact. Once the point of reference is 
established, the tool automatically takes the four lateral measurements and then the user can save 
the values to a spreadsheet. The process is repeated for all available vertebra and then for each 
daily MVCT scan. As a note, data for some of the vertebra was missing due to some patients not 
being scanned with the same consistent set of slices each day. This was corrected for by linearly 





3.1.2 Reduction of Dimensionality 
The dimensionality of all data sets is extremely high, so all data was broken up for each 
vertebra. For example, patient 1 was treated for 40 treatment fractions and 4 lateral 
measurements were taken for all 5 vertebra. If the data is separated by vertebra, then the results 
are five 40X4 matrices (4 measurements at each observation). If separated by measurement, then 
the result is four 40X5 matrices. The next consideration was the number of models that should be 
created. It was assumed that, instead of combining all measurements from all vertebrae together, 
a more meaningful approach would be to create 4 models, one for each cross-sectional 
measurement. The rationale for this approach will be discussed later in the results section.  
Even after partitioning the data to build 4 different models, a large amount of data still 
exists, so a trimmed mean was performed for all measurements with respect to each vertebra in 
order to reduce the dimensionality of the data. The built-in MATLAB function “trimmean” was 
used for this process, where for a matrix input X, the output m is a row vector containing the 
trimmed mean of each column of X. The function works by calculating the mean of X, while 
excluding the highest and lowest (percent/2) percent, which is a scalar between 0 and 100.  
The trimmed mean is a robust estimate of the location of a sample. If there are outliers in 
the data, the trimmed mean is a more representative estimate of the center of the body of the data 
than just the mean. The highest and lowest 25% of the data was excluded, meaning that only half 
of the data was used to calculate a new (condensed) representation of each measurement. This 
value was chosen because visual inspection of the data showed that usually there were only two 




To clarify this operation, consider the example presented in Figure 9, which shows an 
example of how the trimmed mean was performed to reduce the dimensionality of the data. First, 
a 2nd order polynomial line was fitted for each measurement taken (totaling 16 lines per patient) 
because most of the data visually followed this type of trend. Next, the regression coefficients for 
each line were calculated and then a trimmed mean was performed in order to get a new set of 
regression coefficients. Finally, these new coefficients are used to calculate a line which 
represents the underlying trend for the previously existing measurements.  
 Figure 10 illustrates the results from performing a trimmed mean for the measurements 
taken at the C1-C4 levels.  It can be seen that the dimensionality of the data is reduced while still 
preserving a representation of the underlying trend of the rest of the data. The “trimmed mean” 
line shown in BLUE STARS in the figure was plotted as a result of the new calculated regression 
coefficients. The other lines are simply shown to illustrate how the new line is a valid 
representation of the original data. 
Visual inspection of the data allowed for the detection of outliers, meaning those lines 
whose slopes did not follow the rest of the data. For example, Figure 11 shows one patient's 
cross-sectional measurements over a period of 46 treatments. It illustrates how the measurement 
taken at C1-C3 followed the same decreasing trend (and whose slope was negative), but the 
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To summarize, a trimmed mean was performed for all measurements, and the 
dimensionality of the data was reduced. So now for a patient with R number of treatment 
fractions, the dimensionality is reduced from four matrices with a dimension of [RX5] to four 
[RX1] vectors. This results in just four measurement lines per patient instead of using the 
original 16. It should also be noted that all measurements taken at vertebra 5 were excluded due 
to a lack of patient data and non-contributory support for the remainder of the data. Also, from 
this point forward the term “measurement (number) x” will refer to the resulting line from which 
a trimmed mean was performed, where x is one, two, three, or four.  
 
3.2 DESCRIPTION OF THE DIAGNOSTIC PROCESS 
 The first part of the IGRT tool is intended to help in identifying patients who would 
require/benefit from adaptive therapy, meaning either the construction of a new mask or the 
creation of a new treatment plan. After the first few measurements are taken, an estimate needs 
to be made as to whether or not (within some amount of confidence) a patient might need ART. 
Because the physicians (i.e. oncologists) do not always have the ability or the time to evaluate 
each patient’s daily MVCT scan for changes, this part of the tool allows for taking measurements 
and then reporting back to the doctor if closer attention is required.  
 In order to correctly notify the oncologist of a potential problem, there needs to be some 
sort of criterion that, when reached, would be considered a means for implementing ART, 
whether it be to make a new mask or develop a better radiation treatment plan. According to the 
physician who treated all of the H&N patients in this study, a change of 0.5 cm in any of the four 




clinical radiation therapy setting, half of a centimeter is considered the threshold for 
repositioning patients and thereby reducing setup and treatment error. Therefore, using the same 
value was the rationale behind selecting a cross-sectional measurement threshold.  
 
3.2.1 Tools for Diagnosis 
 The next section will describe the methods used for detecting trends in the cross-sectional 
measurement data. The ultimate goal of the diagnostic part of the IGRT tool is to identify those 
patients who will meet the physician-specified criteria for re-evaluation of treatment. The answer 
to the question for this part of the tool is a simple "yes" or "no." 
 
Trend Detection 
Visual inspection of the data shows that most patients’ cross-sectional measurements 
either decreased to some extent or had basically no change over the course of treatment. A 
decrease is acceptable as along as it does not cause the immobilization device to become 
ineffective, but if the decrease is too severe, the patient might need to have a new mask made 
and/or a new treatment plan developed.  
It was hypothesized that patients who had significant decreasing trends in their cross-
sectional measurements would be candidates for adaptive therapy. The data from each individual 
measurement was tested using the Mann-Kendall (MK) test [Dietz & Killeen 1981], which is a 
non-parametric multivariate statistical test used for the detection of monotone trends. The test 




As opposed to parametric trend detection methods, the MK test makes no assumption with 
regards to the functional form of the trend.  
For the MK test formalism, let: (X1, X2…Xn) be a sequence of measurements observed 
sequentially over time. The hypotheses to be tested are: 
H0: the observations are randomly ordered; 
H1: the observations have a monotonic trend over time. 
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If H0 is the true test statistic, then KX is asymptotically distributed according to the Normal 







A confidence interval of α = 0.95 was used for each test.  
 The Mann-Kendall test was the first technique used with the data. A few patients’ 
measurements displayed no change over the course of treatment. However, because most patients 
experienced some sort of decline in their measurements, the test basically identified all patients 
as those with trends. This information is not very useful in terms of identifying those patients 
whose measurements are significantly decreasing, so another method, rates of change, was used 




Change in Measurement 
 Another method for evaluating trends, or behavior of the data, is to simply look at the rate 
of change, or the change in each measurement over a given period of time. As mentioned before, 
because most of the data follow a decreasing trend, a 2nd order polynomial was fitted, and the 
regression coefficients were calculated. Once the regression coefficients are known for the first 
few observations, the data can then be extrapolated out to see where (if at all) the threshold of 0.5 
cm is crossed for any of the four measurements. If the threshold is predicted to actually be 
crossed, then a flag should be put up to say that a patient’s measurements will cross 0.5 cm at 
some point in the future.  
 To illustrate this method we will first examine the true patient data. Figure 13 shows the 
four true measurements for Patient 8. Recall that these lines are the result of reducing the 
dimensionality of the data, and were calculated by using a trimmed mean technique on the 
regression coefficients. The data lines are shown as BLUE stars and the RED dotted lines were 
calculated by subtracting 0.5 cm from the patient’s first data point and then plotted straight 
across the figure's x-axis. The crossing point, shown as MAGENTA x’s is the point where the 
measurement (in BLUE) changes by 0.5 cm (RED).  
For example, measurement one in the figure begins with a value of approximately 7.4 
cm. Also recall that measurement "one" was taken laterally from the center of the patient’s head 
to the right side of the face, which is represented as the solid red line in Figure 12. Therefore, if a 
measurement of the cross-section is taken and is less than 6.9 cm, then the physician-specified 




course, is at the discretion of the physician, but it is necessary to at least communicate that the 
patient is undergoing significant anatomical changes so that an informed decision can be made.  
One case where the oncologist might not request a new mask is when a measurement 
crosses by 0.5 cm, but the patient only has a few treatments remaining. This can be seen in 
Figure 14 where Measurement One for Patient 8 appears to cross the threshold at 27/30 
treatments, and Measurement Two crosses at 26/30. The feasibility of constructing a new mask 
should also be taken into account; however this issue was not addressed and is also at the 
discretion of the doctor.  
Other patient demographic data, such as weight loss, primary disease site, disease stage, 
and chemotherapy were considered useful in making a diagnosis. For example, if a patient lost a 
certain percent of their overall body weight after the first few treatments, then this could be used 
as an indicator along with cross-sectional measurement changes for making a diagnosis. 
Appendix B contains a table which reports the weight loss data that was collected for each of the 
30 patients. When possible, weights at the beginning and end of treatment were recorded and the 
total percent of body weight lost was calculated.   
 






















































































































































Figure 14: No measurements cross the 0.5 cm threshold 
 




































































































































3.2.2 Measure of Reliability  
 In order to provide meaningful results from the diagnostic part of the tool, some sort of 
reliability measure is needed to provide confidence with which a decision is to be made. In other 
words, if a patient’s initial measurements suggest that the 0.5 cm threshold will eventually be 
crossed, then “how sure” are we, that a request for re-evaluation should be made to the 
oncologist. This is important from an efficiency standpoint, in that there is no point in wasting 
the doctor’s time, essentially, unless the reliability is high that a measurement will cross the 
threshold.  
Traditional reliability analysis involves the collecting of statistical information which can 
reveal the underlying mechanism with which a system will fail. Therefore, a correlation analysis 
was carried out for the measurements taken at each vertebra to see if this information could be 
used as a measure of reliability. As a note, the built-in MATLAB function corr.m was used to 
calculate all correlation coefficients. 
All of the collected data was done so retrospectively which allowed for the analysis of 
completed data sets. Information was also available concerning which patients had large 
reductions in their cross-sectional measurements, as well when their measurements changed by 
more than 0.5 cm. This information was used in the modeling process discussed in the next 
section, and it was shown that, as more observations (measurements) were made, the correlation 
of the data increased, and the percent error with which a prediction was made then decreased. 
Therefore, the correlation information proved to be a valid means for reporting preliminary 




3.3 DESCRIPTION OF THE PROGNOSTIC PROCESS 
As mentioned before, when a patient loses weight or has significant anatomical response, 
normal structures may shift into areas of higher dose or the actual tumor volume may have 
changed so much that it is no longer receiving the complete radiation prescription. The questions 
to be answered in this work can be thought of as part of a prognostic process, where, given a 
current state and point in time, predict the future state at the correct time. The area of prognostics 
is not the main focus of this dissertation. However, the prognostic framework used to solve 
common problems in industry can be applied to the data at hand in order to make a prediction.  
For example, a classic prognostic system in industry involves predicting when all or part 
of a machine will fail. In this process, statistical data that are collected for the object of interest 
are used to evaluate some degradation parameter, which leads to an understanding of the 
underlying failure mechanism. Then, the best-suited prognostic model is chosen so that a reliable 
prediction for failure can be made. Common terms used in prognostic systems are “remaining 
useful life,” “degradation process,” and “time to failure,” which have similar meaning to the 
terms used when describing a patient’s anatomical response to radiation. This type of system is 
very similar to the one presented in this dissertation. Up to this point, statistical correlation data 
has been acquired and the underlying trend of the data is understood. The next and final step in 
the process is to make a reliable prediction about when a patient would require adaptive radiation 
therapy.      
This section will describe how a time prediction can be made, which is the basis for the 
second part of the IGRT tool. Once an answer to the first question is found, then the data and its 




patient's cross-sectional measurements will (if ever) cross the threshold of 0.5 cm. This is of 
particular importance because it allows for pre-allocation of time and resources of the clinical 
staff to prepare for an adaptive course of treatment. And as a note, the “point in time” is assumed 
in terms of the treatment number where the threshold is crossed. In reality, patients are only 
treated during a typical work week (Monday – Friday), but the predicted “point in time” is based 
on the assumption that a patient is treated everyday of the week. This is a minor detail, however 
it is important to clarify that time is really treatment number instead of elapsed number of days. 
 
3.3.1 Prediction Model Selection 
 The ultimate deciding factor in model selection should be how well a given model can 
characterize the data. Two types of modeling techniques, non-parametric and parametric, are 
commonly used to make future predictions when given a set of data. A non-parametric model is 
defined by historical data and a process for applying the historical data to estimate new query 
observations. An example is weighted regression, where the historical data are memory vectors 
selected from normal, fault-free system behavior. This non-parametric technique involves 
estimating the similarity of a query observation to memory vectors in order to determine weights 
and perform a weighted average of the memory vectors. A parametric model, in contrast, is 
defined by a set of parameters and a mathematical framework for applying the parameters. An 
example is linear regression, where the parameters are the regression coefficients and the 
mathematical framework is a known function which uses the parameters to define the behavior 






   Initially, the task of identifying patients who required adaptive therapy was considered 
in terms of a classification problem, where data from "old" patients were used to predict the class 
of "new" patients. For example, if one H&N patient exhibited significant change in the first few 
treatments, then that patient would be classified differently than one whose cross-sectional 
measurements showed little change. Then once a database of pre-classified patients was formed, 
new patient data could be compared to old data in order classify that new patient. For this 
problem, the classes were "abnormal" or "normal", where abnormal patients' measurements 
significantly decreased over the course of treatment, where normal patients' measurements did 
not. So initially a non-parametric kernel regression technique was used to predict which patients 
would require adaptive radiation therapy.  
The basis of kernel regression is to estimate a response using a weighted average of point 
in a training set, which are local to the query point. For this study, the training set contained all 
of the historical cross-sectional measurement data. This data had been previously evaluated so 
that each patient was already classified as abnormal or normal. Since the classes are already 
known, the kernel classification model can learn the relationships present in the historical data. 
This type of model is slightly different than typical types of kernel regression models because the 
output is not a prediction of cross-sectional measurements, but the class to which a certain 
patient belongs (abnormal or normal). So, a patient whose measurements cross the 0.5 cm 
threshold would be classified as abnormal, whereas those who do not would be considered 
normal.  





1. The distance of the query input (new data) to each of the vectors in the memory 
matrix (historical data) is calculated. There are many distance functions available, 
but the most common is the Euclidean distance, also known as the L2-norm. For a 






)(),(  (3.3) 
 
where: X is the memory vector of historical data,   
q is the query observation 
 
For a single query vector, this calculation is repeated for each of the memory 
vectors which then results in a matrix of distances. 
 
2. The distances are then supplied as inputs into the kernel function, which converts 
the distances into weights. A kernel function is used to transform the distance 
between the query point and observation into a similarity, or normalized weight. 
In general, query data points which are “close” to the memory matrix data points 
are weighted more heavily, so large distances should have small weights and 
small distances will have large weights. One commonly used function is the 



















where: d is the distance calculated in Equation 3.5, 
h is the kernel's bandwidth   
 
The kernel's bandwidth, h, is used to control which distances are considered "local." If a 
bandwidth is too large, the predictions are over-smoothed and all classifications will be the same, 
and a small bandwidth will restrict the number of available training points in the vicinity of the 
test points.   
 
3. The last step is to use the weights calculated in Equation 3.6 to make a prediction. For 
classification problems, the standard kernel estimation technique is modified to 
estimate the probability of the new dataset, belonging to one of two classes. This 
modified type of kernel classification comes from an application for classification 
using kernel product estimators and a decision rule [Cooley & MacEachern 1998]. 


























where: xi is the i
th
 training observation, 




 K is the Gaussian kernel function (Equation 3.6) 
 n is the total number of training observations, 
 
Extrapolation-Based Prediction 
 In contrast to the kernel regression method, a parametric extrapolation-based model was 
constructed, where a polynomial function and its regression coefficients are used for model 
development. The equation for a second-order polynomial, or quadratic, is commonly known as: 
 
y(t) =b0 + b1t + b2 t
2 (3.6) 
 
where b0, b1, and b2 are the linear regression coefficients. The function y(t) is defined to be an 
approximating curve that provides the best fit of the collected measurements. Once the 
regression coefficients are known for certain measurements, a prediction is made through 
extrapolation of y(t) in a moment of time (t) in the future. The rationale for using this type of 
model is that the underlying characteristic of the data appears to decrease gradually over time; 
therefore complex modeling is not necessary and a generic parametric model is well-suited for 
the data.  
 
3.3.2 Reliability Metric 
 The term "reliability" in this dissertation is similar to the reliability of a machine (and its 
parts) whose performance is monitored for signs of failure. The concepts of “remaining useful 




“closeness to crossover.” In the diagnostic part of the IGRT tool, correlation of the data was 
discussed as a reliability measure after identifying patients who would need a new mask. 
Because the prognostic part of the tool involves making a prediction as to when a new mask or 
treatment plan is required, another measure, the "closeness to crossover" was combined with 
correlation to provide confidence or some reliability for the time predictions. An example of how 
this extra measure was calculated will be discussed later in this section.     
The effectiveness of the immobilization device is affected by great reductions in cross-
sectional measurements. For example, at the beginning of a patient's treatment a new mask is 
made, and it is molded specifically for that patient. It is assumed that this mask will remain tight 
and fitted on the patient's head each day, however if anatomical changes or weight loss occur, the 
mask could become loose enough that the patient is able to move their chin and/or head around 
inside the mask. This is undesirable for two reasons:  
 
1. All patients have marks put on their skin so that an alignment can be made using the 
stationary in-room lasers. For head and neck patients, these marks are placed on the 
outside of the mask, which also are used for patient setup. 
2. Radiation is being delivered at the head, near critical structures such as the brain, 
eyes, nerves, and the spinal cord. Once the mask is no longer immobilizing the 
patient, a new one should be made in order to avoid irradiating these structures.  
  
The remaining useful life or the effectiveness of the mask is assumed to be 100% at the 




patients head to prevent movement. However, if significant changes in cross-sectional 
measurements occur, then the effectiveness, and therefore the “remaining life” of the mask 
decrease as well. An effectiveness value is not used as a reliability measure of this system, 
although it is directly related to the closeness to crossover value which is used to determine 
reliability of a prediction.  
As discussed previously, the regression coefficients for the trimmed lines were calculated 
and then these were the basis for a prediction. Also, the correlation coefficients of the 
measurements proved to be an effective measure of reliability. However, because true error can 
not be assessed during the course of a patient's treatment, the "closeness to crossover" value can 
be used as part of the reliability metric.   
The “closeness to crossover” value is actually just the answer the following question: 
How close in proximity are the cross-sectional measurements to changing by more than 0.5 cm? 
It can be thought of as the used “life” of the facemask, where the values range from 0 to 1, with 0 
signifying that the mask has 100% of its “life” left and 1 meaning no “life” left. It is calculated 
according to Equation 3.7: 














1   (3.7) 
where Ct

 is the predicted time of crossover and t  is the time at which a prediction is being made 
(the current time). To clarify, the extrapolation model is given 15 observations (starting at 
observation 1) for each of the four measurements. After the 15th observation, the model predicts 




observations, and recall that the prediction is made by extrapolating out the regression 
coefficients. When the change in measurement is greater than 0.5 cm, then the model finds the 
point in time where this happens, or Ct

. The predicted “closeness to crossover” value is then 
calculated by plugging in Ct

 and the current time point (t) into Equation 3.6. Consider Figure 15, 
an example for just one of the four measurements for Patient 8.  
The model has predicted that the measurement will have changed by 0.5 cm at Ct

 = 15. 
This can be seen because the measurement taken at the first time step is 7.265, so (7.265 – 0.5) 
cm = 6.765. The first value to be equal to or less than this value is 6.742 cm, located at time 15. 
The “closeness to crossover” is calculated for each real time step t, where a value of 1 indicates a 
predicted threshold crossover. A new crossover value is calculated every time an observation is 
added, so a “closeness to crossover” value can be found for any time step through the course of 
treatment.  
Because the correlation coefficients were already proved as a valid measure of reliability, 
closeness to crossover values were averaged with the correlation values, which resulted in a 
value for overall reliability. Figure 16 illustrates how the correlations of the data as well as the 
closeness to crossover values are quite similar and follow the same trend. The x-axis is the 
treatment number and the y-axis is a scale from -1 to 1, where at zero, neither the data is very 
correlated nor are the patient’s measurements close to crossing the 0.5 cm threshold. But, one 
can see that both increase together. The closeness to crossover is a useful addition to reporting 




crossing the 0.5 cm threshold. The next section will discuss the results from the diagnostic and 
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 The next section will present the results from the two components of the IGRT tool. The 
diagnostic results identify those patients who will require adaptive therapy (i.e. a new facemask 
or new treatment plan), and the prediction results relay the point in time when the cross-sectional 
measurement data crosses the threshold of the physician-specified criteria. Because the goal of 
this tool is to evaluate new patients for whom no previous data exists, these predictions start after 
the patient has received 15 treatments and then continual predictions after each proceeding 




 The first set of results identifies (with some reliability) which patients’ measurements 
will cross the 0.5 cm threshold at some point in the future. As discussed previously, it is 
necessary to evaluate each measurement individually because the physician is interested in 
knowing if any of the four measurements change by more than 0.5 cm. It would be helpful to 
diagnose patients as early as possible while still being somewhat sure, therefore a reliability 
value will be given after each of the diagnoses.  
 
4.1.1 Data Set Selection 
 
Before displaying the results from the diagnostic process, it is first necessary to address 
the isssue of data selection for this part of the tool. As mentioned previously, demographic 




standardized. To clarify, the data were collected by reading through each patient's chart in an 
attempt to find out as much demographic information as possible. However, it was found that 
patient charts are often unorganized and it impossible to ensure that all demographic information 
was completely documented.  
One example of this was that some patients’ weights were not recorded consistently and 
were also only taken once a week at most. Often, there would be no record of beginning weight 
or the first record would occur after the first 10 treatments. Therefore, weight loss could possibly 
be an indicator that a patient will require adaptive therapy, but having inconsistent and missing 
data for this work proved the opposite. The rest of the demographic information proved to be 
unhelpful as well. It is believed that relying on this type of data would only be possible for 
patients who were under a clinical trial where all variables are under strict control, whereas the 
patients in this study were just chosen at random for evaluation. Therefore, only the cross-
sectional measurement data was used for training and testing. 
Another data set selection issue was also mentioned previously, and that is the one of 
how many models should there exist for each patient. All four lateral measurements were plotted 
for C1-C4. Figure 16 shows the four measurements taken at the C3 level for one of the patients. 
It is apparent that there is a wide range in physical measurement, from almost 8 cm to 6.5 cm. 
Also, after visual inspection of the data, each vertebra's measurements did not seem to follow the 
same trend always. Therefore, instead of using the 4 lateral measurements for each vertebra as 
data for the model, all of the "ones", "twos", "threes", and "fours" were pulled out for each 




Another advantage to taking this approach is that the model is given 4 measurements that 
should all have about the same trend, therefore having some redundant information provides for 
robust modeling and a better chance for making an accurate diagnosis/prediction. Also, 
symmetry of measurement change can be visually evaluated. For example, if meaurements 1 and 
2 (which are on the right side of the face) are changing rapidly and measurements 3 and 4 are 
changing slowly, one could assume that this was the result of asymmetric anatomical response, 
whereas if all 4 measurements are changing rapidly, one could identify that patient as having a 
symmetric anatomical response, which would most likely be attributed to overall weight loss. 
Distinguishing between tumor response and overall weight loss was not one of the major 
contributions in this work, however the tool does allow for plotting any of the data for any of the 
patients’ measurements. Therefore, the physician could visually inspect the plots if he/she were 
interested in knowing what type of anatomical response is occurring. 
 
4.1.2 Diagnosing ART Candidates 
 Two methods, trend detection and change in measurement, were previously discussed as 
possible ways to identify patients who will require adaptive therapy in the future. The results 




The Mann-Kendall test for trend detection worked. However, sometimes when a trend 
was detected, it was not very significant in terms of a patient requiring ART. As stated before, 




the MK test did return accurate results because it simply tests for a decreasing trend. Therefore, 
the results were visually inspected and a “professional decision” was made as to which patients 
were considered abnormal or normal, using a threshold criteria of a 0.5 cm change over the entire 
course of treatment. As a note, each of the four measurements was kept with their respective 
vertebra when evaluating trends. 
Patients were classified as either normal or abnormal; where abnormal were those whose 
measurements crossed the 0.5 cm threshold and the normal did not. Figure 17 shows an example 
of one patient’s cross-sectional measurements over the course of 32 treatments, and Figure 18 
shows a different patient’s measurements over the course of 45 treatments. The first figure 
visibly shows a significant decreasing trend over the course of treatment and would be 
considered as abnormal. However the second figure only shows a slight decrease over time, so 
this would be normal change in measurement, meaning not enough change for a patient to 
require adaptive therapy. As mentioned before, the MK test can not provide qualitative results 
about the magnitude with which a trend is occurring, only if the data is “trendy” or not. 























































































To reiterate the method, 4 different lateral measurements were taken at the C1-C4 
vertebral levels and then each measurement was taken out from its respective vertebra level. The 
result is having all of the "ones", "twos","threes", and "fours" put together to create 4 different 
models for each patient.   
 
Change in Measurement 
The changes in cross-sectional measurement were first calculated by starting with the 
first 15 observations and extrapolating out the trimmed mean lines (i.e. each of the four 
measurements). A prediction is made about whether or not we think any of the measurements 
will cross the 0.5 cm threshold. Also, the average correlation coefficients (which are squared and 
do not include any negatively correlated values) are reported, giving a measure of the prediction 
reliability. 
All true patient data was tested to see which patient’s (and each one specifically) 
measurements crossed the 0.5 cm threshold. Tables 2-4 show the results from that testing, 
including the correlation values for the data, and all of the data from these tables (excluding 
correlation values) were plotted for each patient and can be found in Appendix B. For each 
measurement (1-4) the true crossing point is listed along with how well the data was correlated. 
Another important value to note is the total number of treatments. For example, Measurement 1 
for Patient 12 shows a true crossing time at 46/46 treatments, and the correlation of the data has a 
value of 0.955. In the prognostic part of the tool, if the model predicts that the measurement 
never crosses the threshold, there would be some error associated with that prediction; however 




should be noted when evaluating the performance of the prediction model, which will be 























2 15 0.990 Y 
3 26 0.948 Y 





2 22 0.995 Y 
3 39 0.985 Y 





2 - 0.910 Y 
3 - 0.919 Y 





2 32 0.441 M 
3 - 0.891 Y 





2 - 0.234 N 
3 - 0.858 Y 





2 - 0.720 Y 
3 - 0.950 Y 





2 11 0.963 Y 
3 28 0.806 Y 





2 26 0.988 Y 
3 17 0.981 Y 





2 36 0.991 Y 
3 32 0.914 Y 





2 - 0.859 Y 
3 - 0.893 Y 























2 - 0.652 Y 
3 30 0.985 Y 





2 42 0.997 Y 
3 - 0.821 Y 





2 22 0.974 Y 
3 16 0.856 Y 





2 12 0.995 Y 
3 14 0.971 Y 





2 20 0.994 Y 
3 13 0.992 Y 





2 - 0.560 M 
3 21 0.720 Y 





2 16 0.611 Y 
3 20 0.503 M 





2 - 0.402 M 
3 - 0.501 M 





2 - 0.465 M 
3 - 0.892 Y 





2 21 0.986 Y 
3 23 0.930 Y 























2 38 0.937 Y 
3 36 0.915 Y 





2 14 0.995 Y 
3 20 0.981 Y 





2 13 0.575 M 
3 - 0.939 Y 





2 - 0.938 Y 
3 38 0.545 M 





2 - 0.356 M 
3 - 0.555 M 





2 - 0.903 Y 
3 - 0.427 M 





2 - 0.920 Y 
3 - 0.778 Y 





2 37 0.978 Y 
3 - 0.593 M 





2 - 0.900 Y 
3 - 0.367 M 





2 - 0.977 Y 
3 - 0.448 M 




 Table 5 shows the results for diagnosing those patients who would have benefited from 
adaptive therapy, whether it was receiving a new facemask or a new treatment plan. In order to 
make a diagnosis, the first 15 observations were given. This is an assumption that was made due 
to the fact that all 30 patients underwent an average of 39 treatments (a total of 1180). It would 
be desirable to make a diagnosis early in treatment, so beginning with 15 observations seemed 
feasible since this is just below half of the average number of treatments. As a note, because 
there are 4 measurements per patient, and each measurement was modeled individually, there are 
actually 120 total diagnoses being made.  
There are two different results for the diagnostic process. The first is those patients who 
will require a new mask at some point during their treatment. The table below shows which 
patients were believed to need adaptive therapy at some point in their treatment given the first 15 
observations, indicated by Y/N. Secondly, if a decision could not be made in the first 15 
observations (indicated by a "?"), then the point at which a reliable diagnosis could be made is 
shown as the treatment number/total number of treatments. There were only 3 measurements, 











































1 Y  
11 
1 Y  
21 
1 ? 29/40 
2 Y  2 ? 32/39 2 N  
3 Y  3 ? 24/39 3 N  
4 ? 20/40 4 ? 17/39 4 ? 19/40 
2 
1 Y  
12 
1 ? 16/46 
22 
1 ? 25/38 
2 Y  2 ? 18/46 2 Y  
3 Y  3 ? 19/46 3 Y  
4 ? 33/44 4 ? 30/46 4 ? 25/38 
3 
1 N  
13 
1 N  
23 
1 Y  
2 N  2 ? 16/42 2 Y  
3 N  3 ? 38/42 3 N  
4 N  4 ? 23/42 4 N  
4 
1 ? 23/38 
14 
1 Y  
24 
1 ? X 
2 ? 32/38 2 Y  2 N  
3 N  3 ? X 3 N  
4 N  4 ? 20/38 4 N  
5 
1 N  
15 
1 Y  
25 
1 ? 30/38 
2 N  2 Y  2 ? 25/38 
3 N  3 Y  3 N  
4 N  4 Y  4 ? 25/38 
6 
1 N  
16 
1 N  
26 
1 ? 20/39 
2 N  2 N  2 ? 20/39 
3 ? 17/36 3 ? 17/35 3 ? 20/39 






1 Y   
17 
1 ? 25/46 
27 
1 ? 16/47 
2 Y   2 Y   2 ? 18/47 
3 ? 25/34 3 ? 23/46  3 ? 16/47 
4 Y   4 Y  4 ? 16/47 
8 
1 Y   
18 
1 ? 26/51 
28 
1 N   
2 ? 26/32 2 N   2 ? 21/45 
3 Y   3 N   3 ? 28/45 
4 ? 20/32 4 N   4 Y   
9 
1 ? 25/42 
19 
1 ? 27/40 
29 
1 N   
2 ? 20/42 2 ? 20/40 2 ? X 
3 ? 37/42 3 N   3 ? 26/41 
4 N   4 N   4 Y   
10 
1 Y   
20 
1 Y   
30 
1 ? 27/46 
2 ? 19/30 2 Y   2 ? 21/46 
3 ? 17/30 3 ? 30/33 3 ? 18/46 









The diagnosis results show that approximately half (61/120) of the measurements 
predicted that patients would need ART within the first 15 observations and 28/120 required 20 
observations to make a reliable diagnosis. Therefore, 74% of patients' measurements accurately 
diagnosed patients would need adaptive therapy within the first 20 observations. While it does 
take 20 observations to have fairly accurate results, it is important to remember that the average 
number of treatments that all 30 head and neck patients underwent was 39 treatments.  
As mentioned previously, 11 of the 30 patients clearly did not require adaptive therapy 
(indicated by dashed lines in Tables 2-4), while 4 were questionable, meaning the crossover 
points were very close to the end of their treatment. Therefore, half of the patients more than 
likely needed to have a new facemask constructed and/or the development of a new treatment 




Obviously early on in treatment, a prediction could be unstable or inaccurate, but as more 
observations are added there is more information used to make a prediction. There were a few 
questions about the reliability of the data, because as mentioned before, some patients had a 
significant amount of data missing from their data sets. Appendix B contains a table which 
shows the percentages of data that were missing and then corrected for by linear interpolation. 
From the table it can be seen that 9 patients' data consisted of more than 25% interpolated data, 
and the reliability in these patient's measurements could potentially reduce the reliability of a 




As discussed before, correlation information was used as part of the reliability measure 
for diagnosis, because it was found that percent error decreased as the correlation of the data 
increased, and the next figures just illustrate this result. Average percent error and the correlation 
of the data were tested for five of the thirty data sets. Figures 19 and 20 show the results from 
two of the cases. It can be seen that, in general, as the correlation of the measurements goes up, 














































































































4.2.1 Kernel Classification 
 Once a database of pre-classified patients is formed, measurements for any new patient 
can be taken and used to determine if they would be a candidate for ART. For the predictions, 
data from 30 patients were included and a leave-one-out cross validation method was used. The 
kernel classification model was able to accurately predict those patients whose assumed true 
category (class) was abnormal. For the assumed normal cases, 13 were identified as normal and 
2 were identified as abnormal. Table 6 illustrates the results in a confusion matrix.  
   
 
 
Table 6: Kernel Classification prediction results 
 
 
15 15 Total 
15 2 Abnormal 
0 13 Normal 





The problems with the kernel classification model are twofold:  
 
1. The database of pre-classified patients was formed by visually inspecting the trend of 
patients’ measurements (at each vertebral level) and attempting to classify them by a 
“professional opinion.” This was, as mentioned before, because the results from the 
Mann-Kendall test reported that all of the data was “trendy” and therefore that all 
patients should be classified as abnormal. Because this was known to be false, a 
professional decision was made as to which patients were classified as abnormal or 
normal.  
2. The data used for the memory matrix should have been separated out by measurement 
rather than all for each vertebra. Also, the rate of change would have been more 
helpful for making a prediction than just using the measurements themselves.  
 
This non-parametric classification technique is useful in industry problems because 
relationships of data can be learned and predicted in the future. However, the problem presented 
in this dissertation involves human data, which often exhibit unexplainable trends and 
unpredictable results. Because the behavior of the data is very particular for a given patient, it 
was decided that the employed prediction method should be specific for each new patient rather 





4.2.2 Extrapolation Model 
 As explained in the methodology section, the basis for the extrapolation model is to take 
the first few observations of a patient’s measurements and extrapolate out (using regression 
coefficients from the prediction line thus far) to make a prediction about what point in time the 
0.5 cm threshold will be crossed. So in the beginning, if the model is given 15 observations, a 
time prediction is made, and a new time prediction and reliability value are then given each time 
an observation is added.  
For this portion of the tool, an "accurate" prediction was determined by evaluating the 
variation after a series of time predictions. For example, assume for times 10-15 that the 
predictions for crossing were at treatments 12, 13, 14, 13, and 14, respectively. The variation in 
these numbers is very low, so the standard deviation for every "last 3 predictions" was used as an 
indicator as to how "sure" one is that a crossover (at the 0.5 cm threshold) is about to occur. If 
the variation (i.e. standard deviation) in the "last 3 predictions" is less than 3, then the correlation 
value and the closeness to crossover value are averaged at that point and reported as the measure 
of reliability. If the reliability at that point is high, meaning greater than 0.5, then the predicted 
crossover time at that point is assumed to be the correct crossover time. However, if the 
reliability value is less than 0.5, the model continues on with predictions until a reliable 








Table 7 only displays results for the 15 patients who should have received adaptive 
therapy and how accurately a predicted crossover time was reported after being given the first 15 
observations. As mentioned before, reliability measures greater than 0.5 are considered as being 
reliable.  












1 * 0.66 Y 
2 * 0.52 Y 
3 * 0.37 N 
4       
2 
1 * 0.61 Y 
2 * 0.54 Y 
3 * 0.34 N 
4       
7 
1 * 0.82 Y 
2 * 0.76 Y 
3       
4 * 0.88 Y 
8 
1 * 0.76 Y 
2       
3 * 0.44 N 
4       
10 
1 * 0.57 Y 
2       
3       
4 * 0.99 Y 
11 
1 * 0.54 Y 
2       
3       
4       
13 
1 * 0.93 Y 
2       
3       





1 * 0.80 Y 
2 * 0.75 Y 
3       
4       
15 
1 * 0.89 Y 
2 * 0.76 Y 
3 * 0.95 Y 
4 * 0.88 Y 
16 
1 * 0.27 N 
2 * 0.29 N 
3       
4       
17 
1       
2 * 0.55 Y 
3       
4 * 0.62 Y  
20 
1 * 1.00 Y 
2 * 0.61 Y 
3       
4       
22 
1       
2 * 0.46 N 
3 * 0.62 Y 
4       
23 
1 * 0.83 Y 
2 * 0.53 Y 
3 * 0.36 N 
4 * 0.29 N 
28 
1 * 0.55 Y 
2       
3       









Because the most important result from the IGRT tool is the time prediction, it is 
necessary to evaluate the accuracy, and more specifically in terms of the amount of “lead time” 
after making that prediction. For example, suppose at treatment number 10, measurement “one” 
(for patient “x”) predicts that the 0.5 cm threshold will be crossed at treatment number 15, given 
a reliability value of greater than 0.5. If the measurement however, does not cross until treatment 
20, then the staff will essentially have 5 days of “lead time” for preparation. Therefore, it is 
desirable to give as much lead time as possible.  
The convenient aspect of the tool is that predictions (and reliability values) are 
continuously generated for each measurement throughout the course of a patient’s treatment. In 
other words, if the model reliably predicts early on (say at treatment 8) that a given measurement 
will cross at treatment 15 and then at treatment 15 the measurement has not quite crossed, new 
predictions can be made until the variation in time predictions slows. As the variation in time 
predictions decreases, the predicted closeness to crossover should increase, thus increasing the 
reliability in each prediction.  
Tables 8-10 show the prediction results with reliabilities of 0.5, 0.6, and 0.7, respectively. 
The results are given in (a) confusion matrices, where the number of predicted and true 
crossovers can be seen. Also, the accuracy with which a prediction is made is given for each 
class, crossover or no crossover, as well as an overall measure of accuracy. The second part of 
the table (b) illustrates the prediction windows, where the average number of days to make a 
prediction is given. Another important piece of information is how many days in advance one is 
notified that a patient will require adaptive therapy. As mentioned before, this is the key result 




resources. Therefore, the time was split into: more than 5 days, 1-4 days, and no lead time (0 
days).  
For example, Table 8 (b) shows that it takes an average of 11 days to make predictions 
with a reliability value of at least 0.5. Also, 57% of predictions were given with at least 5 days to 
make preparations, 14% with 1-4 days, and 29% with no lead time. Obviously, it is desirable to 
know more than 0 days before a patient will require ART. So, Tables 9 and 10 show the results 
for making predictions with higher reliability values (0.6 and 0.7). It can be seen that both have 
similar results, where a prediction is made (more than 80% of the time) knowing at least 5 days 
ahead of time. This means that, perhaps, a reliability of 0.65 should be used when reporting 
"highly reliable" predictions. The tables show that, while it does require more days to make a 
higher prediction, the amount of significant “lead time” (i.e. more than 5 days ahead) increases 
from 57% to 86% with 7 extra observations. This result suggests that predictions should continue 
to be made (even after a reliability value of 0.5 is found) until a reliability of close to 0.7 is 








Table 8: Prediction results for a reliability > 0.5  
 
 











Average number of observations to 
make a prediction 
 
  Crossover No Crossover 
 57.0% 











1-4 treatments ahead of actual 
crossover 
No Crossover 6 6 50.0% 
 
29.0% No Lead Time (0 treatments ahead) 
 




























Average number of observations to 
make a prediction 
 
  Crossover No Crossover 
 90.0% 












1-4 treatments ahead of actual 
crossover 
No Crossover 6 6 50.0% 
 
10.0% No Lead Time (0 treatments ahead) 
 













Table 10: Prediction results for a reliability > 0.7 
 
  











Average number of observations to 
make a prediction 
 
  Crossover No Crossover 
 82.6% 











2-4 treatments ahead of actual 
crossover 
No Crossover 9 3 60.0% 
 
8.7% No Lead Time (0 treatments ahead) 
 







The next series of figures (Figures 21-28) shows the results for Patient 11. They illustrate 
measurements 1-4 being predicted after 10 and then 15 observations. Each figure contains 3 
subplots, where the first illustrates the prediction line, predicted crossover point, and true 
crossover point. The x-axis for all subplots is the number of treatments and the y-axis for the first 
is the cross-sectional measurement value in centimeters.  
The second subplot shows the error with which the prediction is made along with the true 
closeness to crossover, which was calculated knowing the true point of crossover. For this 
subplot, the y-axis ranges from 0 to 1. As discussed previously, the closeness to crossover values 
range from 0 to 1, where values approaching 1 indicate that a crossover is about to occur. The 
error was calculated as a percent; however it was normalized on a scale of 0 to 1 in order to 
compare it to the crossover values. Therefore an error value of 1 really indicates 100% error.   
The last subplot shows the predicted value versus the true value of closeness to crossover. 
Once again, the y-axis is a scale from 0 to 1, where a crossover, be it predicted or true, equals a 
value of 1. The second and third subplots can be interpreted together, where the predicted 
closeness to crossover should be indirectly proportional to the error associated with that 
prediction. The true closeness to crossover values are just plotted to illustrate how accurate the 
model is making a prediction over time, because obviously when a new set of data are presented, 
the true crossover point is unknown.  
Figures 20 and 21 shows the results from a prediction made after 10 and then 15 
observations, respectively. In Figure 20, subplot 1, it can be seen that the predicted line crosses 
the 0.5 cm threshold at treatment number 20, indicated as RED diamonds, whereas the true 




closeness to crossover value is increasing over time, yet not quite to 1 which means that no 
crossover has actually occurred. Also, the error starts out high (as expected) and then decreases 


















































 At this point it is necessary to point out one important aspect of the modeling process. 
Although predictions can be made every time an observation is added into the data set, if an 
accurate crossover prediction is made for a certain measurement, then there is essentially no need 
to continue adding in additional data. At that point, the information would be given to the 
physician so that the patient could be re-evaluated for the need to construct a new facemask or 
create a new treatment plan.  
 The analysis of the cross-sectional measurement data provided interesting results related 
to which patients should have had a new facemask made and the ones which actually had a new 
mask made during the course of treatment. Patients 11 and 17 were the only 2 patients who had 




(including 11 and 17) actually needed some form of adaptive therapy, and likely a new 
facemask. Figure 29 shows the fused images for Patient 17 right before a new mask was 
constructed, and can be used to validate the results for this patient.  
 It can be seen in the figure that the areas of the patient's face that show anatomical 
response correspond with the location with which Measurements 2 and 3 were taken. Going back 
to Table 7, we can see that an accurate prediction was made for both measurements within 15 
observations and slightly more for measurements 1 and 4. This means that after 15 observations, 
the physician could have been notified that a change greater than 0.5 cm would occur around 
treatment 25.  
  
 





































The focus of this dissertation was to use cross-sectional measurement data collected from 
archived CT scans to create a tool for determining which patients will require and benefit from 
adaptive radiation therapy, specifically for the purpose of creating a new facemask and/or a new 
radiation therapy treatment plan.  
It has been shown that many head and neck cancer patients undergo significant 
anatomical changes which might make them a candidate for adaptive radiation therapy. The 
facemask is an important part of ensuring accurate and reproducible radiation therapy treatments, 
therefore it is imperative that ineffective masks be identified and replaced. Also, significant 
changes in cross-sectional measurements could cause normal structures to shift into the treatment 
field and result in escalated doses to health tissue. This could result in an inaccurate treatment 
delivery; therefore a patient might require a new treatment plan along with a new facemask.  
The task of identifying those patients who would benefit from ART was achieved by 
collecting cross-sectional measurements of 30 patients' face and neck regions, and using the 
newly developed two-part IGRT to identify those patients who would need a new mask and/or 
treatment plan. Also, a time prediction was made as to when this was required so that the clinical 
staff can allocate time and resources to prepare for adaptation of a patient’s treatment course. 
The cross-sectional measurement data is truly an indicator for patients requiring new masks, 
however they are also valuable in identifying those patients who might need a new treatment 




Fifteen H&N patients were identified as ones who should have had a new facemask 
constructed. The reality is that only 2 patients received new masks, and the delayed toxicities 
experienced by the other patients could have possibly been prevented with the construction of a 
new mask. The cross-sectional data proved to be an accurate representation of the anatomical 
changes that each patient underwent. In other words, the predicted change in cross-sectional 
measurement (for all 120 measurements) was used to correctly diagnose 74% of the 
measurements that would require a patient to require adaptive therapy. Also, the prediction 
results for those correctly diagnosed show that an average of 11 days are needed to ensure a 
reliability of 0.5, while an even more reliable prediction can be made (reliability = 0.7) if 18 
observations are initially supplied.    
 
5.1 RECOMMENDATIONS FOR FUTURE WORK 
 
 The focus of this dissertation was on the development of a tool which will aid the 
oncologists in deciding which H&N patients will require adaptive radiation therapy. This is 
needed because it will allow for the allocation of time and effort of the clinic staff to adequately 
prepare for a new plan. It can also alert the oncologist as to which patients will require close 
monitoring during their course of therapy.   
In the future, the proposed methodology could be extended in the following directions: 
- Develop a classification scheme by using rates of change of data and then further 
develop the proposed modified kernel regression model to predict which patients 




work in this dissertation, in that one would actually attempt to make a prediction 
based on historical patient data.    
- Further evaluate the “abnormal” patients, who are the ones who have undergone 
weight loss or tumor response. This will require the utilization of the rate of change 
results. For example, if the rate of change is the same for all four lateral 
measurements, it could indicate weight loss, whereas an asymmetric rate of change 
might point to tumor response. The work done in this dissertation allows for 
making the distinction between these two patients. However, the results are 
deduced by visually evaluating the plots of the measurement data. More analysis 
could involve tabular results and a more complex set of if/then rules.  
- Integrate the IGRT tool into software programs that control IGRT machines, 
specifically those with MVCBCT capabilities. It is known that MVCBCT is an 
excellent imaging source for H&N patients because it can provide for increased 
contrast between bone and soft tissue and decreased noise in its images. With these 
types of images, the center of each vertebra could be automatically found and then 
measurements could be taken by the radiation therapists while the patient is 
undergoing treatment. This would provide the medical physicists with the data on a 
weekly basis and then they could report to the oncologist as to what type of 
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A.1 ADDITIONAL DEMOGRAPHIC INFORMATION 
 This section includes weight loss information collected for each patient. It also reports 
those patients who required the construction of a new facemask, indicated in YELLOW. The two 
















of Weight Lost 
(%) 







1 176 158 18 10.2 60 n 
2 102.5 95 7.5 7.3 68 n 
3 135.5 116 19.5 14.4 55 n 
4 194 183.5 10.5 5.4 63 n 
5 144 136 8 5.6 54 n 
6 109 109 0 0.0 57 n 
7 220 162.5 57.5 26.1 71 n 
8 198.5 182 16.5 8.3 47 n 
9 153 131.5 21.5 14.1 62 n 
10 132.5 140 N/A N/A 43 n 
11 194 176 18 9.3 74 y 
12 218 202.5 15.5 7.1 48 n 
13 152 146.5 5.5 3.6 62 n 
14 196 168 28 14.3 65 n 
15 212 192 20 9.4 62 n 
16 179.5 150 29.5 16.4 62 n 
17 298.5 261 37.5 12.6 60 y 
18 171.5 168.5 3 1.7 47 n 
19 58 70.5 N/A N/A 64 n 
20 160.5 137 23.5 14.6 58 n 
21 163.5 152 11.5 7.0 55 n 
22 230 209 21 9.1 50 n 
23 156 148 8 5.1 34 n 
24 185 170.5 14.5 7.8 59 n 
25 139.5 139.5 0 0.0 46 n 




27 211.5 202.5 9 4.3 63 n 
28 232 215.75 16.25 7.0 63 n 
29 193 176 17 8.8 65 n 


































































































































































































































































































































































B.1 MEASUREMENT DATA FOR ALL 30 PATIENTS 
The first set of figures in this appendix are intended to illustrate how a reduction of the 
dimensionality of the data was done for each patient and each measurement. To reiterate the 
method, 4 different lateral measurements were taken at the C1-C4 vertebral levels and then each 
measurement was taken out from its respective vertebra level. The result is having all of the 
"ones", "twos","threes", and "fours" put together to create 4 different models for each patient.   
The figures following these show which patients experienced anatomical changes that 
caused their cross-sectional measurements to change by more than 0.5 cm, indicated by the 
vertical lines and labelled "Measurement Crossover." The result from these measurement 
changes indicates a need for a new facemask, however it was previously discussed that only 2 





































































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover





































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover



















































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover



















































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover




































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover



















































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover







































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover


























































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover





















































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover

























































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover

























































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover










































































































































































   Measurement One Crossover
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   Measurement Three Crossover























































































































































































   Measurement One Crossover
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   Measurement Three Crossover
















































































































































































   Measurement One Crossover
   Measurement Two Crossover
   Measurement Three Crossover
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B.2 CONFERENCE PRESENTATION AND AWARD 
Harris, C, A. Usynin, R.  Seibert, and C. Ramsey (2008) “A Novel Technique for Predicting 
Which Head & Neck Patients will Require Adaptive Therapy”, Proceedings of the 50th Annual 
American Society of Radiologic Therapeutic Oncology (ASTRO) Conference, (72) pp.S84-85, 
2008. 
 
This submission includes the preliminary results presented in this proposal. The presentation at 
the conference showed the methodology used for the initial developments of the IGRT tool.  
 
This submission was selected as the physics winner of the Resident Clinical Basic Science 
Research Award, which is the highest award given at this conference for medical physics 
residents.  
 








 Carley Harris was born in Jackson, TN on November 1, 1982. She moved to Dickson, TN 
before the beginning of high school and eventually graduated from Dickson County High School 
in May 2001. She began attendance at the University of Tennessee, Knoxville in the summer of 
2001 and graduated with her Bachelor of Science in Biomedical Engineering in May 2005 and 
with her Masters of Science in Nuclear Engineering in May 2007. 
 As an undergraduate, she was a teaching assistant for the Freshman Engineering 
Fundamentals Program (Engage) for 2 years and then would eventually become a graduate 
teaching assistant for the Honors Section of the program. After entering the Nuclear Engineering 
Department, she worked for the Engage program, took graduate classes, and volunteered at the 
Thompson Cancer Survival Center for almost 2 years. It was at the cancer center where she 
conducted research under the direction of Dr. Chester Ramsey, and would eventually become 
employed as a Medical Physics Resident for 2 years.  
 She has completed and presented 5 conference publications as the primary author and has 
co-authored 8 other conference publications. 
 While at the University of Tennessee, she was a member of the Pride of the Southland 
Marching Band for 2 years, playing piccolo the first year and then baritone the second year. She 
was also a member of Gamma Sigma Sigma National Service Sorority for 2 years.    
